Keyphrases
Phase Separation
93%
Transcriptional Condensates
76%
Super-enhancer
50%
Nuclear Condensate
50%
Transcription Factor
50%
Condensation
40%
Coactivator
39%
Gene Control
38%
Gene Expression
36%
Phase-separated Condensates
30%
Activation Domain
25%
MED1
25%
Separation Control
25%
Solid-solid Interface
25%
Separation Capacity
25%
Thermodynamic Properties
25%
Cis-regulation
25%
Biological Specificity
25%
Cooperative Interaction
25%
Polymer Mixtures
25%
Transcriptional Control
25%
Phosphorylation
25%
Multicomponent Polymers
25%
Long Non-coding RNA (LncRNA)
25%
Chemical Potential
25%
Polymerase II
25%
Phase Separation Model
25%
Transcription Initiation
25%
Interacting Components
25%
Autoimmunity
25%
Gene Activity
25%
Genetic Programming
25%
Coexisting Phases
25%
T Cell Antigen Receptor
25%
Cancer Therapeutics
25%
Physicochemical Properties
25%
Feedback Control
25%
RNA-based
25%
Small Molecules
25%
Vitamin D
25%
T Cell Development
25%
Phosphatidylinositol Transfer Protein
25%
Reactivity Ratios
25%
Phosphatidylinositol-4
25%
T Cell Survival
25%
Radical Copolymerization
25%
Dynamic Approach
25%
Replenishment
25%
Chemical Dynamics
25%
Antigen Receptor Signaling
25%
Biochemistry, Genetics and Molecular Biology
Phase Separation
100%
Enhancer Region
79%
Transcription
65%
Transcription Factors
50%
Gene Expression
44%
RNA
34%
Mediator
32%
Gene Control
31%
Genomics
30%
Cell Function
25%
Pharmacodynamics
25%
Vitamin D
25%
Gene Activity
25%
MED1
25%
Polymerase
25%
Small Molecule
25%
Long Noncoding RNA
25%
C-Terminus
25%
Autoimmunity
25%
Evolution
25%
Transcription Initiation
23%
Gene Activation
19%
BRD4
17%
Dynamics
14%
Long Non-Coding RNA
14%
Enzyme
12%
Cross Reaction
12%
Lethal Mutation
12%
Nucleic Acid
12%
DNA-binding Domain
12%
Drug Activity
12%
Morphology
12%
Nucleation
12%
Gene Organization
12%
Gene Cluster
12%
DNA Sequence
10%
Immune Response
8%
Kinetics
8%
Drive
7%
Splicing Factor
7%
Cyclin-Dependent Kinase
7%
Transcription Factor GCN4
6%
Estrogen Receptor
6%
Amino Acids
6%
Mediator (Coactivator)
6%
T Cell
5%
Immunity
5%